“…APP acts as a presynaptic CAM to trans-synaptically regulate GABAergic synaptic strength and synapse number, and these parameters are negatively tuned by the action of postsynaptic MDGA1 in the dendritic, but not somatic, compartment of hippocampal CA1 pyramidal neurons (middle). AMPAR, α-amino-3-hydroxy-5-methyl-4-isoxacolepropionic acid receptor; APP, amyloid precursor protein; CAM, cell adhesion molecule; Cbln, cerebellin precursor; DG, dentate gyrus; GABA A R, γ-aminobutyric acid type A receptor; GluD, glutamate receptor δ family; IgSF, immunoglobulin superfamily; LEC, lateral entorhinal cortex; LRRTM, leucine-rich repeat transmembrane protein; Lphn, latrophilin; MDGA1, MAM domain-containing glycosylphosphatidylinositol anchor protein 1; MEC, medial entorhinal cortex; NMDAR, N-methyl-D-aspartate receptor; Nrxn, neurexin; PV, parvalbumin; PTPσ, protein tyrosine phosphatase sigma; SLM, stratum lacunosum-moleculare; SP, stratum pyramidale; SO, stratum oriens; SR, stratum radiatum; SST, somatostatin; Sub, subiculum in the medial, but not lateral, perforant pathway, [88] indicating that LRRTM3 is critical in conferring neural circuit specificity. LRRTM3 cKO neurons exhibit enhanced neurotransmitter release, which might regulate the excitability of DG granule neurons and MF-LTP, [88] suggesting that medial perforant and MF pathways activities are inter-dependent.…”